THE DEFINITIVE GUIDE TO PMTA 0 11

In addition, it addresses the FDA’s communications Together with the applicant, the retention of information that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of an SE report to a different applicant and electronic submission with the SE